Results 241 to 250 of about 30,002 (370)
Association of the IL-10 and IL-18 polymorphisms with nasopharyngeal carcinoma risk. [PDF]
Chen X+5 more
europepmc +1 more source
Proteomic analysis of cystic fibrosis transmembrane conductance regulator knockout (CFTR‐KO) clones of 16HBE14o‐ cells showed altered pathways linked to inflammation, polymorphonuclear leukocyte (neutrophil) recruitment, and epithelial–mesenchymal transition.
Domenico Mattoscio+19 more
wiley +1 more source
Intra-Parotid Recurrent Nasopharyngeal Carcinoma Following Intensity-Modulated Radiation Therapy: A Case Report. [PDF]
Bourial A+10 more
europepmc +1 more source
The protease ADAMTS5 controls ovarian cancer cell invasion, downstream of Rab25
Metastatic progression is characterised by extensive remodelling of the extracellular matrix, primarily mediated by secreted proteases, including ADAMTS family members. Rainero and colleagues found that the small GTPase Rab25 promoted the expression of ADAMTS5 in ovarian cancer cells through the activation of the NF‐κB signalling pathway.
Shengnan Yuan+7 more
wiley +1 more source
Pre-treatment and post-treatment nasopharyngeal carcinoma imaging: imaging updates, pearls and pitfalls. [PDF]
Li KY+4 more
europepmc +1 more source
ABSTRACT Objective To analyse sex differences in health‐related quality of life (HRQL) before, during and up to 3 months posttreatment of head and neck cancer, and to examine the importance of salivary secretion rate for HRQL posttreatment. Methods Patients were recruited before starting curative oncologic treatment.
Niklas Bohm+4 more
wiley +1 more source
Head and Neck Squamous Cell Carcinoma: Insights from Dual-Energy Computed Tomography (DECT). [PDF]
Bicci E+9 more
europepmc +1 more source
Long-term outcomes of radiotherapy for inoperable benign soft tissue tumors in the skull base or head. [PDF]
Chung JH+4 more
europepmc +1 more source
ABSTRACT Aims To translate the Supportive and Palliative Care Indicators Tool (SPICT) into Chinese and conduct preliminarily tests of its performance in hospitalized patients with cancer. Design A cross‐sectional validation study conducted from January to March 2024.
Yufei Huang+4 more
wiley +1 more source
Identification of RNA processing factor LSM5 as a new adverse biomarker in nasopharyngeal carcinoma. [PDF]
Lin T+7 more
europepmc +1 more source